Immunotherapy Coverage from Every Angle
Advertisement
Advertisement

Recent News

TAT 2020: IL-18 and Anticancer Immunity in Prostate Cancer
Head/Neck Cancers Symposium 2020: Immunotherapy Plus TKIs in Metastatic Thyroid Cancer
New Receptor Protein May Successfully Target Multiple Myeloma Cells
RTK Inhibitor Plus Immunotherapy in Advanced Kidney Cancer
Can Influenza Vaccines Trigger Immune Response in Patients With Lung Cancer?
Combination Therapy for Enzalutamide-Resistant Prostate Cancer
FDA Accepts Biologics License Application for Proposed Biosimilar to Bevacizumab
FDA Accepts Biologics License Application for Proposed Biosimilar To Bevacizumab
Bempegaldesleukin and Adoptive Cell Transfer Therapy: Preclinical Melanoma Model
FDA Accepts Biologics License Application for Proposed Biosimilar to Bevacizumab
Head/Neck Cancers Symposium 2020: SBRT Plus Pembrolizumab in Previously Irradiated Squamous Cell Carcinoma
FDA Accepts BLA for Fixed-Dose Combination Therapy for HER2-Positive Breast Cancer
Isatuximab-irfc Combination Therapy for Multiple Myeloma Approved by FDA
GU Cancers Symposium 2020: Update From CheckMate 214 on First-Line Nivolumab Plus Ipilimumab for Kidney Cancer
Can TKIs Combined With Interferon-α Enhance Immunosuppressive State in CML?
TAPUR Results for Cobimetinib Plus Vemurafenib in Colorectal Cancer
Addition of Gemtuzumab Ozogamicin to Induction Therapy in AML
Atezolizumab Receives FDA Priority Review in NSCLC
GI Cancers Symposium 2020: AVETUX Regimen in Metastatic Colorectal Cancer
GU Cancers Symposium 2020: Savolitinib Plus Durvalumab in Papillary Renal Carcinoma
GU Cancers Symposium 2020: Dual Immune Checkpoint Inhibition With Radiation for Kidney Cancer
ASCO-SITC 2020: Sociodemographics and Receipt of Immunotherapy in Advanced Melanoma
Daratumumab-Based Combination Therapy for Newly Diagnosed Multiple Myeloma
ASCO-SITC 2020: Genetics Research Hints at Regulator of T-Cell Responses in Colorectal Cancer
GU Cancers Symposium 2020: Long-Term Data Support Nivolumab vs Everolimus in Kidney Cancer
ASCO–SITC 2020: Interim Trial Results With Pepinemab/Avelumab in Advanced NSCLC
Can Influenza Vaccines Trigger Immune Response in Patients With Melanoma?
GI Cancers Symposium 2020: Pertuzumab Plus Trastuzumab in HER2-Positive Colorectal Cancer
ASCO-SITC 2020: Radiation Recall Pneumonitis and Nivolumab for Lung Cancer
Phase I Trial Results With Immunotherapy bb21217 for Resistant Multiple Myeloma
ASCO-SITC 2020: Is Immune Primer in Renal Cell Cancer Ready for Prime Time?
Dynamics of DNA Methylation in CLL Patients Treated With Chemoimmunotherapy
NCI-MATCH Study: Next Phase for Nivolumab Beyond Colorectal Cancer
Matching Tumor Mutations to Treatment for Salivary Gland Cancer
GI Cancers Symposium 2020: TAPUR Study Findings for Pembrolizumab in Colorectal Cancer
B and T Immune Cells: A Biomarker of Response to Immunotherapy for Breast Cancer?
GI Cancers Symposium 2020: Quality-of-Life Results From the BEACON CRC Trial


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.